Advertisement

Topics

Medicrea Reports First Half 2017 Sales and Operating Highlights

07:38 EDT 3 Oct 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
First half 2017 sales of €14.7 million 1,700 UNID™ patient-specific surgeries performed to date Received FDA 510(k) Clearance for UNiD™ HUB software platform Commercial launch of PASS® TULIP top...

Other Sources for this Article

Medicrea
Denys Sournac
Founder, Chairman and CEO
dsournac@Medicrea.com
or
Fabrice Kilfiger
Chief Financial Officer
Tel: +33 (0)4 72 01 87 87
fkilfiger@Medicrea.com

NEXT ARTICLE

More From BioPortfolio on "Medicrea Reports First Half 2017 Sales and Operating Highlights"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...